High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway

References

• Palermo A, D’Onofrio L, Buzzetti R, Manfrini S, Napoli N. Pathophysiology of bone fragility in patients with diabetes. Calcif Tissue Int. 2017;100:122–132. doi:10.1007/s00223-016-0226-3
   PubMed Web of Science ®Google Scholar
• Cortet B, Lucas S, Legroux-Gerot I, et al. Bone disorders associated with diabetes mellitus and its treatments. Joint Bone Spine. 2019;86:315–320. doi:10.1016/j.jbspin.2018.08.002
   PubMed Web of Science ®Google Scholar
• Shu A, Yin MT, Stein E, et al. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2012;23:635–641. doi:10.1007/s00198-011-1595-0
   PubMed Web of Science ®Google Scholar
• Nilsson AG, Sundh D, Johansson L, et al. Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material strength and poorer physical function in elderly women: a population-based study. J Bone Miner Res. 2017;32:1062–1071. doi:10.1002/jbmr.3057
   PubMed Web of Science ®Google Scholar
• Acevedo C, Sylvia M, Schaible E, et al. Contributions of material properties and structure to increased bone fragility for a given bone mass in the UCD-T2DM rat model of type 2 diabetes.. J Bone Miner Res. 2018;33:1066–1075. Epub ahead of print doi:10.1002/jbmr.3393.
   PubMedGoogle Scholar
• Zeitoun D, Caliaperoumal G, Bensidhoum M, et al. Microcomputed tomography of the femur of diabetic rats: alterations of trabecular and cortical bone microarchitecture and vasculature – a feasibility study. Eur Radiol Exp. 2019;3:17. doi:10.1186/s41747-019-0094-5
   PubMedGoogle Scholar
• Burr DB. Cortical bone: a target for fracture prevention? Lancet. 2010;375:1672–1673. doi:10.1016/S0140-6736(10)60444-8
   PubMedGoogle Scholar
• Patsch JM, Burghardt AJ, Yap SP, et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res. 2013;28:313–324. doi:10.1002/jbmr.1763
   PubMed Web of Science ®Google Scholar
• Kerckhofs G, Durand M, Vangoitsenhoven R, et al. Changes in bone macro- and microstructure in diabetic obese mice revealed by high resolution microfocus X-ray computed tomography. Sci Rep. 2016;6:35517. doi:10.1038/srep35517
   PubMedGoogle Scholar
• Talbot J, Brion R, Lamora A, et al. Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts. J Cell Physiol. 2018;233:946–957. doi:10.1002/jcp.25938
   PubMedGoogle Scholar
• Zhao S, Zhang Y, Harris S, Ahuja SS, Bonewald LF. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res. 2002;17:2068–2079. doi:10.1359/jbmr.2002.17.11.2068
   PubMed Web of Science ®Google Scholar
• Plotkin LI. Connexin 43 hemichannels and intracellular signaling in bone cells. Front Physiol. 2014;5:131. doi:10.3389/fphys.2014.00131
   PubMedGoogle Scholar
• Rochefort GY, Pallu S, Benhamou CL. Osteocyte: the unrecognized side of bone tissue. Osteoporos Int. 2010;21:1457–1469. doi:10.1007/s00198-010-1194-5
   PubMed Web of Science ®Google Scholar
• Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell … and more. Endocr Rev. 2013;34:658–690.
   PubMed Web of Science ®Google Scholar
• Mabilleau G, Perrot R, Flatt PR, Irwin N, Chappard D. High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone. 2016;90:99–106. doi:10.1016/j.bone.2016.06.008
   PubMedGoogle Scholar
• Cunha JS, Ferreira VM, Maquigussa E, Naves MA, Boim MA. Effects of high glucose and high insulin concentrations on osteoblast function in vitro. Cell Tissue Res. 2014;358:249–256. doi:10.1007/s00441-014-1913-x
   PubMed Web of Science ®Google Scholar
• Rochefort GY. The osteocyte as a therapeutic target in the treatment of osteoporosis.pdf. Ther Adv Musculoskelet Dis. 2014;6:79–91. doi:10.1177/1759720X14523500
   PubMedGoogle Scholar
• Moorer MC, Stains JP. Connexin43 and the intercellular signaling network regulating skeletal remodeling. Curr Osteoporos Rep. 2017;15:24–31. doi:10.1007/s11914-017-0345-4
   PubMedGoogle Scholar
• Xu H, Gu S, Riquelme MA, et al. Connexin 43 channels are essential for normal bone structure and osteocyte viability. J Bone Miner Res. 2015;30:436–448. doi:10.1002/jbmr.2374
   PubMedGoogle Scholar
• Kar R, Riquelme MA, Werner S, Jiang JX. Connexin 43 channels protect osteocytes against oxidative stress-induced cell death. J Bone Miner Res. 2013;28:1611–1621. doi:10.1002/jbmr.1917
   PubMed Web of Science ®Google Scholar
• Davis HM, Aref MW, Aguilar-Perez A, et al. Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice. JBMR Plus. 2018;2:206–216. doi:10.1002/jbm4.v2.4
   PubMedGoogle Scholar
• Xu H, Liu R, Ning D, et al. Biological responses of osteocytic connexin 43 hemichannels to simulated microgravity. J Orthop Res. 2017;35:1195–1202. doi:10.1002/jor.v35.6
   PubMedGoogle Scholar
• Yu C, Huang D, Wang K, et al. Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK/p38 MAPK activation. Mol Med Rep. 2017;15:543–550. doi:10.3892/mmr.2016.6047
   PubMedGoogle Scholar
• Zhang H, Ji L, Yang Y, et al. The therapeutic effects of treadmill exercise on osteoarthritis in rats by inhibiting the HDAC3/NF-KappaB pathway in vivo and in vitro. Front Physiol. 2019;10:1060. doi:10.3389/fphys.2019.01060
   PubMed Web of Science ®Google Scholar
• Cherian PP, Siller-Jackson AJ, Gu S, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell. 2005;16:3100–3106. doi:10.1091/mbc.e04-10-0912
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu S, Hu S, Wei Y. Cardiomyopathy-associated Gene 1-Sensitive PKC-dependent connexin 43 Expression and phosphorylation in left ventricular noncompaction cardiomyopathy. Cell Physiol Biochem. 2017;44:828–842. doi:10.1159/000485348
   PubMedGoogle Scholar
• Kerschnitzki M, Kollmannsberger P, Burghammer M, et al. Architecture of the osteocyte network correlates with bone material quality. J Bone Miner Res. 2013;28:1837–1845. doi:10.1002/jbmr.1927
   PubMed Web of Science ®Google Scholar
• Holzer G, von Skrbensky G, Holzer LA, Hip PW. Fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009;24:468–474. doi:10.1359/jbmr.081108
   PubMed Web of Science ®Google Scholar
• Rockoff SD, Sweet E, Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969;3:163–175. doi:10.1007/BF02058659
   PubMedGoogle Scholar
• Samelson EJ, Demissie S, Cupples LA, et al. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: framingham HR-pQCT study. J Bone Miner Res. 2018;33:54–62. doi:10.1002/jbmr.v33.1
   PubMed Web of Science ®Google Scholar
• Sellmeyer DE, Civitelli R, Hofbauer LC, et al. Skeletal metabolism, fracture risk, and fracture outcomes in Type 1 and Type 2 diabetes. Diabetes. 2016;65:1757–1766. doi:10.2337/db16-0063
   PubMed Web of Science ®Google Scholar
• Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95:5045–5055. doi:10.1210/jc.2010-0226
   PubMed Web of Science ®Google Scholar
• Wagner AS, Glenske K, Wolf V, et al. Osteogenic differentiation capacity of human mesenchymal stromal cells in response to extracellular calcium with special regard to connexin 43. Ann Anat. 2017;209:18–24. doi:10.1016/j.aanat.2016.09.005
   PubMedGoogle Scholar
• Batra N, Riquelme MA, Burra S, et al. Direct regulation of osteocytic connexin 43 hemichannels through AKT kinase activated by mechanical stimulation. J Biol Chem. 2014;289:10582–10591. doi:10.1074/jbc.M114.550608
   PubMed Web of Science ®Google Scholar
• Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5:464–475. doi:10.1016/j.cmet.2007.05.001
   PubMed Web of Science ®Google Scholar
• Bivi N, Nelson MT, Faillace ME, et al. Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone. Calcif Tissue Int. 2012;91:215–224. doi:10.1007/s00223-012-9628-z
   PubMedGoogle Scholar
• Moorer MC, Hebert C, Tomlinson RE, et al. Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation. J Cell Sci. 2017;130:531–540. doi:10.1242/jcs.197285
   PubMedGoogle Scholar
• Gerdhem P, Isaksson A, Fau-Akesson K, Obrant KJ, Obrant KJ. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005;16:1506–1512. doi:10.1007/s00198-005-1877-5
   PubMed Web of Science ®Google Scholar
• Yang L, Meng H, Yang M. Autophagy protects osteoblasts from advanced glycation end products-induced apoptosis through intracellular reactive oxygen species. J Mol Endocrinol. 2016;56:291–300. doi:10.1530/JME-15-0267
   PubMedGoogle Scholar
• Fong JT, Kells RM, Gumpert AM, et al. Internalized gap junctions are degraded by autophagy. Autophagy. 2012;8:794–811. doi:10.4161/auto.19390
   PubMed Web of Science ®Google Scholar
• Li X, Liu C, Li P, et al. Connexin 43 is a potential regulator in fluid shear stress-induced signal transduction in osteocytes. J Orthop Res. 2013;31:1959–1965. doi:10.1002/jor.v31.12
   PubMedGoogle Scholar
• Lloyd SA, Loiselle AE, Zhang Y, Donahue HJ. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling. Bone. 2013;57:76–83. doi:10.1016/j.bone.2013.07.022
   PubMedGoogle Scholar
• Grimston SK, Goldberg DB, Watkins M, et al. Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis. J Bone Miner Res. 2011;26:2151–2160. doi:10.1002/jbmr.425
   PubMedGoogle Scholar
• Lee RH, Sloane R, Pieper C, et al. Glycemic control and insulin treatment alter fracture risk in older men with Type 2 diabetes mellitus. J Bone Miner Res. 2019;34:2045–2051. doi:10.1002/jbmr.v34.11
   PubMed Web of Science ®Google Scholar